Intraabdominal Continuous Hyperthermic Peritoneal Perfusion for Patients with Advanced Gastric Cancer-Present and Future.
スポンサーリンク
概要
- 論文の詳細を見る
Reasonable extent of lymphadenectomy in combination with perioperative reliable adjuvant countermeasure to prevent postoperative peritoneal metastasis, as a prophylactic therapy is indispensable to improve the results of surgical treatment of gastric cancer with serosal invasion. Further therapeutic modality should be improved to obtain life prolongation for patients with gastric cancer with disseminating peritoneal metastasis or for gastrectomized patients with postoperative peritoneal metastasis. We believe that intraoperative continuous hyperthermic peritoneal perfusion (CHPP) combined with intraabdominal chemotherpy would be a candidate for the most reliable adjuvant therapy as both prophylactic and therapeutic modalities against peritoneal metastasis from gastric cancer.
- 日本ハイパーサーミア学会の論文
日本ハイパーサーミア学会 | 論文
- わが国における温熱療法のあゆみと現状:2004年のアンケート調査
- 癌治療における併用療法としての低温度温熱処置の有用性について
- The Biology of Heat-induced DNA Double-Strand Breaks
- 良好な生存率を示した非小細胞肺癌の化学療法とハイパーサーミアの併用療法
- 温熱感受性ならびに温熱効果の修飾について